Company Edwards Lifesciences Corporation Xetra

Equities

EWL

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - Xetra 09:05:41 17/05/2024 pm IST After market 12:17:20 am
81.79 EUR -1.53% Intraday chart for Edwards Lifesciences Corporation 81.64 -0.18%

Business Summary

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:

- heart valves and surgery products (67.9%);

- hemodynamic monitoring systems (15.5%);

- other (16.6%): balloon catheters, artificial implants, etc.

Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).

Number of employees: 19,800

Sales per Business

USD in Million2022Weight2023Weight Delta
Transcatheter Mitral and Tricuspid Therapies
64.6 %
3,518 65.4 % 116 2.2 % 3,880 64.6 % +3,241.77%
Surgical Heart Valve Therapy
16.6 %
893 16.6 % 999 16.6 % +11.89%
Critical Care
15.5 %
855 15.9 % 928 15.5 % +8.55%
Transcatheter Mitral and Tricuspid Therapies
3.3 %
3,518 65.4 % 116 2.2 % 198 3.3 % +70.20%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
58.4 %
3,133 58.2 % 3,509 58.4 % +12.01%
Europe
22.2 %
1,175 21.8 % 1,335 22.2 % +13.59%
Rest of World
11.8 %
601 11.2 % 709 11.8 % +17.92%
Japan
7.5 %
474 8.8 % 452 7.5 % -4.48%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 01/15/01
Director of Finance/CFO 57 01/14/01
Chief Tech/Sci/R&D Officer - 01/19/01
Investor Relations Contact - -
Sales & Marketing - 01/05/01
Corporate Officer/Principal 45 -
General Counsel 46 -
Corporate Officer/Principal 66 01/17/01
Corporate Officer/Principal - 01/11/01
Corporate Officer/Principal 62 01/95/01

Members of the board

Members of the board TitleAgeSince
Director/Board Member 63 05/16/05
Chairman 67 13/14/13
Director/Board Member 72 16/16/16
Director/Board Member 66 13/20/13
Director/Board Member 60 10/15/10
Director/Board Member 58 07/20/07
Chief Executive Officer 56 01/15/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 652,000,000 597,178,790 ( 91.59 %) 49,400,000 ( 7.577 %) 91.59 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
8.808 %
52,964,394 8.808 % 4 661 M €
BlackRock Advisors LLC
6.413 %
38,563,704 6.413 % 3 394 M €
26,775,785 4.453 % 2 357 M €
BNY Mellon Investment Adviser, Inc.
3.155 %
18,973,557 3.155 % 1 670 M €
AllianceBernstein LP
2.957 %
17,781,666 2.957 % 1 565 M €
Brown Investment Advisory & Trust Co.
2.767 %
16,636,146 2.767 % 1 464 M €
Wellington Management Co. LLP
2.586 %
15,549,759 2.586 % 1 369 M €
Geode Capital Management LLC
2.178 %
13,094,626 2.178 % 1 152 M €
BlackRock Life Ltd.
2.141 %
12,874,540 2.141 % 1 133 M €
JPMorgan Investment Management, Inc.
1.459 %
8,775,542 1.459 % 772 M €

Company contact information

Edwards Lifesciences Corp.

1 Edwards Way

92614, Irvine

+949 250 2500

http://www.edwards.com
address Edwards Lifesciences Corporation(EWL)

Group companies

NameCategory and Sector
Medical Specialties
Medical Specialties
Edwards Lifesciences Technology SARL
Medical Specialties
  1. Stock Market
  2. Equities
  3. EW Stock
  4. EWL Stock
  5. Company Edwards Lifesciences Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW